References on the Administration of Barbiturates Using ALZET® Osmotic Pumps

1. Pentobarbital

P5450 Kim,Y., Oh,S. Changes of the level of G protein alpha-subunit mRNA by tolerance to and withdrawal from pentobarbital in rats. Neurochemical Research 2002; 27(-6-):527-533. >>> Pentobarbital; Saline; CSF/CNS; Rat; 2001; 7 days; Controls received mp w/ vehicle; tolerance; dependence; one week recovery period after cannula placement.

P4317 Jang,C.-G., Oh,S., Zho,H., Ho,I.K. Autoradiography of [3H] glutamate binding during pentobarbital tolerance and withdrawal in the rat. Brain Research Bulletin 1999; 48(-1-):99-102. >>> Pentobarbital; Saline; CSF/CNS; Rat; 2ML1; 6 days; Controls received mp with vehicle; tolerance; dependence; animals allowed one week recovery after cannula placement.

P4188 Jang,C.-G., Oh,S., Ho,I.K. Changes in NMDAR2 subunit mRNA levels during pentobarbital tolerance/withdrawal in the rat brain: an in situ hybridization study. Neurochem.Res. 1998; 23(-11-):1371-1377. >>> Pentobarbital; Saline; CSF/CNS; rat; 2ML1; 6 days; controls received mp w/saline; tolerance.

P4177 Oh,S., Wellman,S.E., Ho,I.K. Changes in (3H)forskolin binding to adenylate cyclase and (3H)phorbol dibutyrate binding to protein kinase c in pentobarbital tolerant/dependent rats. Neurochem.Res. 1998; 23(-4-):463-467. >>> Pentobarbital; CSF/CNS; rat; 2ML1; 7 days; guide cannula implanted; rats were allowed 1 week recovery before implantation of pump; tolerance; dependence.

P3852 Oh,S., Hoshi,K., Ho,I.K. Role of NMDA receptors in pentobarbital tolerance/dependence. Neurochem.Res. 1997; 22(-7-):767-774. >>> Pentobarbital; Saline; CSF/CNS; rat; 2ML1; 7 days; controls received mp w/saline; tolerance; dependence.

P3422 Ito,T., Suzuki,T., Wellman,S.E., Ho,I.K. Chronic pentobarbital administration alters g-aminobutyric acid(A) receptor a(6)-subunit mRNA levels and diazepam-insensitive [3H]Ro15-4513 binding. Synapse 1996; 22(--):106-113. >>> Pentobarbital; CSF/CNS; rat; 2ML1; 6 days; tolerance; dependence.

P3421 Suzuki,T., Ito,T., Wellman,S.E., Ho,I.K. An autoradiographic study of [3H]flunitrazepam binding sites in the brain of rat made tolerant to and dependent on pentobarbital. Eur.J.Pharmacol. 1996; 295(--):169-179. >>> Pentobarbital; Saline; CSF/CNS; rat; 2ML1; 6 days; controls received vehicle infusion; tolerance; dependence; recipe for equithesin anesthesia provided on p. 170.

P3351 Suzuki,T., Ito,T., Wellman,S.E., Ho,I.K. Changes in [3H] Flunitrazepam binding in the brain of rats made tolerant to and dependent upon pentobarbital. Life Sci. 1995; 57(-5-):L-69. >>> Pentobarbital; CSF/CNS; rat; 2ML1; 6 days; controls received mp w/saline; tolerance; dependence; animals allowed 1 week recovery after cannula placement.

P3173 Miyaoka,T., Kimura,T., Saunders,P.A., Tseng,Y.T., Ho,I.K. Binding characteristics of [3H]flunitrazepam in pentobarbital-withdrawal rats. Neurochem.Res. 1994; 19(-1-):37-42. >>> Pentobarbital; CSF/CNS; rat; 2ML1; 6 days; controls received mp with saline; animals allowed 1 week recovery after cannula placement.

P3112 Tseng,Y.T., Wellman,S.E., Ho,I.K. In situ hybridization evidence of differential modulation by pentobarbital of GABAA receptor a1- and B3-subunit mRNAs. J.Neurochem. 1994; 63(--):301-309. >>> Pentobarbital; CSF/CNS; rat; 2ML1; 6 days; tolerance.

P3675 Kimura,T., Miyaoka,T., Saunders,P.A., Baker,M.L., Hume,A.S., Yamamoto,I., Ho,I.K. Induction of tolerance to and physical dependence on pentobarbital continuous intracerebroventricular administration. J.Pharmacol.Exp.Ther. 1993; 266(-3-):1300-1305. >>> Pentobarbital, sodium; Saline, normal; CSF/CNS; rat; 2ML1; 6 days; controls received mp w/ filtered, normal saline; tolerance; dependence; good illustration of pump placement (p. 1301).

P3113 Tseng,Y.T., Miyaoka,T., Ho,I.K. Region-specific changes of GABAA receptors by tolerance to and dependence upon pentobarbital. Eur.J.Pharmacol. 1993; 236(--):23-30. >>> Pentobarbital; Saline; CSF/CNS; rat; 2ML1; 6,7 days; controls received mp with saline; tolerance; dependence; animals allowed 1 week recovery after cannula placement; brain and serum samples taken at 0, 2, 4, 7 days during infusion&6, 24, 48 hrs. after withdrawal.

P3111 Tseng,Y.T., Wellman,S.E., Ho,I.K. Differential effects on GABAA receptor y2-subunit messenger RNA by tolerance to and withdrawal from pentobarbital -- an in situ hybridization study. Life Sci. 1993; 53(--):L321-L326. >>> Pentobarbital; CSF/CNS; rat; no duration posted; tolerance.

P2338 Toshiyuki,K., Miyaoka,T., Saunders,P.A., Baker,M.L., Hume,A.S., Yamamoto,I., Ho,I.K. Induction of tolerance to and physical dependence on phentobarbital continuous intracerebroventricular administration. J.Pharmacol.Exp.Ther. 1993; 266(-3-):1300-1305. >>> Pentobarbital; Saline; CSF/CNS; rat; 2ML1; 6 days; tolerance; dependence.

top of page

2. Phenobarbital

R0242 Loescher,W. The pharmacokinetics of antiepileptic drugs in rats: Consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy. Epilepsia 2007; 48(-7-):1245-1258. >>> Levetiracetam; phenobarbital; phenytoin; valproic acid; vigabatrin; Water, distilled; PEG 300; glycerol; PEG 400; propylene glycol; SC; IP; Rat; mice; gerbils; 2ML1; 2ML2; 1-4,2 weeks; 7 days; Comparison of IV, IP injections vs. food or water delivery vs mp; pumps replaced (every week in one set of experiments); stress/adverse reaction: (see pg. 1255); peritoneal irritation, peritonitis in some of the IP experiments); half-life (p. 1247) table 1 (18 compounds); animal info (epileptic, Sprague-Dawley, Wistar); review; see p. 1254-1255; see table 4 for advantages + disadvantages of different applicatoin routes.

P0494 Hock,F.J., Beyhl,F.E. A novel method for the administration of the enzyme inducer phenobarbital to rats via an osmotic minipump. IRSC Med.Sci.: Biochem. 1984; 12(-8-):661-. >>> Phenobarbital; SC; rat; 2002; 8 days; Comparison of phenobarb. consumed po in drinking water vs. mp infusion; author states advantages of mp use.

P0447 Davis,T.P., Schoemaker,H., Culling,A.J. Centrally acting drugs alter in vitro B-endorphin processing in the rat. Eur.J.Pharmacol. 1984; 100(--):249-251. >>> Chlorpromazine; haloperidol; phenobarbital; promethazine; SC; Rat; 2001; 8 days; Comparison of agents effects.

P0401 Kuhnz,W., Zierer,R., Nau,H. A new method for kinetic studies of drug interactions in experimental animals during steady state: controlled-rate application of valproic acid, phenobarbital and their combinations via implanted osmotic minipumps in the mouse. Arzneimittelforschung 1983; 33(-11-):1579-1582. >>> Phenobarbital, sodium; Valproate, sodium; Water; SC; mice (pregnant); 2001; 2002; 1 and 2 weeks; no stress see p. 1580, 1582; 1-2 pumps/animal; VPA and PB used singly and in combination in mp.

P0311 Kapetanovic,I.M., Sweeney,D.J., Rapoport,S.I. Phenobarbital pharmacokinetics in rat as a function of age. Drug Metab.Disp. 1982; 10(-6-):586-589. >>> Phenobarbital; Water; IP; rat; 5 days; bolus injec. vs. mp infusion.

P0036 Tabakoff,B., Ritzmann,R.F., Oltmans,G.A. The effect of selective lesions of brain noradrenergic systems on the development of barbiturate tolerance in rats. Brain Research 1979; 176(--):327-336. >>> Phenobarbital, sodium; Propylene glycol; Water; CSF/CNS; rat; 3 days; some groups given 6-OHDA or vehicle of ascorbic acid in Artificial CSF prior to infusion.

top of page

Looking for references? We can help!

ALZET will perform a custom bibliography search for you! ALZET pumps have been used to deliver hundreds of different compounds, including proteins and peptides, in a myriad of different experimental applications. We have recently updated our database, which now contains over 11,000 references that can help you guide your research project!

Request your ALZET bibliography search!

 

Order the ALZET SurgicalImplantation Video

Researchers are saying ...

“We switched to a 21-day minipumps paradigm using a dose that mimics serum antidepressant concentrations in humans because this regimen resulted in a more consistent and robust decrease in serotonin transporter levels in rats than what is observed with daily injections of serotonin reuptake inhibitors.” Weinshenker et al. 2002 Brain Research 946:239-246.